A Phase I Clinical And Pharmacokinetic Study Of SB939 In Patients With Advanced Cancer.

Trial Profile

A Phase I Clinical And Pharmacokinetic Study Of SB939 In Patients With Advanced Cancer.

Completed
Phase of Trial: Phase I

Latest Information Update: 28 Mar 2016

At a glance

  • Drugs Pracinostat (Primary)
  • Indications Solid tumours
  • Focus Adverse reactions
  • Most Recent Events

    • 21 Jun 2011 Actual end date jun 2011 added as reported by ClinicalTrials.gov record.
    • 21 Jun 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 19 Mar 2010 Status changed from suspended to active, no longer recruiting as reported by National Cancer Institute of Canada.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top